Chronic conjunctivitis can be caused by infection or allergy. Infectious causes include trachoma caused by Chlamydia trachomatis, which is the leading cause of preventable blindness worldwide. If left untreated, repeated trachoma infections can lead to scarring of the conjunctiva and complications like trichiasis and corneal opacity. Granulomatous conjunctivitis presents with localized conjunctival granulomas and lymphadenopathy in conditions like cat scratch disease or tuberculosis. Non-specific chronic conjunctivitis can be caused by chronic irritation or hypersensitivity reactions.
Aphakia and its causes. Correction of Aphakia. Advantages and disadvantages of different corrections. Surgeries and related signs and symptoms of aphakia. Complications related to Aphakia.
Aphakia and its causes. Correction of Aphakia. Advantages and disadvantages of different corrections. Surgeries and related signs and symptoms of aphakia. Complications related to Aphakia.
Non-Gonococcal urethritis. main causative organisms are Chlamydiae, Mycoplasma, Ureaplasma. various other bacteria and viruses can cause this. this powerpoint is made in systemic manner and will be helpful for Postgraduate students.
Diagnosis and Treatment of Canine Pyodermaupstatevet
Ed Jazic, DVM, DACVD
The prevalence of Canine Pyoderma is increasing very quickly and the clinical condition can present in a variety of ways. It is a common secondary manifestation of a variety of clinical conditions like allergic skin diseases, endocrinopathies, autoimmune skin diseases, and keratinization disorders. An efficient and correct diagnosis is essential as is proper therapy in the face of ever-increasing development of Canine Methicillin-Resistant Staphylococcal Pyoderma.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
7. TRACHOMA
The leading cause of preventable blindness in
the world
15 – 20% world’s blindness
Caused by chlamydia trachomatis A , B, Ba &
C
Self limiting disease
Repeated infections + secondary infection
blindness
13. CLINICAL FEATURES
ACTIVE STAGE
CHRONIC STAGE
COMPLICATIONS
ACTIVE
1st
decade
CHRONIC
2nd
decade
COMPLICATIONS
4th / 5th
decade
14. TRACHOMA
CONJUNCTIVA
Congestion, papillae & FOLLICLES
UPPER TARSUS
Follicles - > 5 mm in diameter
along the upper border of the upper
tarsus
NEVER ON THE BULBAR
CONJUNCTIVA
MINUTE STELLATE SCARS
HISTOPATH – aggregations of lymphocytes with
necrosis & leber cells - follicles
26. investigations
mcCoy cell cultures, monoclonal antibody test
& IgA-IPA light microscopy – best combination
CLINICAL DIAGNOSIS:
any 2 of the signs
1.follicles on the upper tarsus
2.superficial keratitis – upper k
3.pannus – upper k
4.limbal follicles/ Herbert pits
5.stellate scars/Arlt’s line – upper tarsus
27. Maccallan classification
STAGES FEATURES
I IMMATURE FOLLICLES , SPK
IIA MATURE FOLLICLES
IIB PANNUS, LIMBAL FOLLICLES, SUPERFICIAL KERATITIS
III FOLLICLES + SCARRING
IV SCARRING
28. WHO CLASSIFICATION [
FISTO]
STAGES FEATURES TREATMENT
FOLLICLES ≥5 FOLLICLES, >0.5MM IN
UPPER TARSUS
NEEDS TREATMENT
NO SCARRING
INTENSE >50% PALPEBRAL BLOOD
VESSELS NOT SEEN
UREGENT
TREATMENT
COMPLICATIONS +
SCARRING TARSAL CONJ SCARRING WITH
WHITE FIBROUS BANDS
INACTIVE
TRICHIASIS ATLEAST ONE TRICHIATIC LASH CORRECTIVE
SURGERY
OPACITIES K OPACITY COVERING
PUPILLARY REGION
29. WHO CLASSIFICATION [
FISTO]
STAGES FEATURES TREATMENT
FOLLICLES ≥5 FOLLICLES, >0.5MM IN
UPPER TARSUS
NEEDS TREATMENT
NO SCARRING
INTENSE >50% PALPEBRAL BLOOD
VESSELS NOT SEEN
UREGENT
TREATMENT
COMPLICATIONS +
SCARRING TARSAL CONJ SCARRING WITH
WHITE FIBROUS BANDS
INACTIVE
TRICHIASIS ATLEAST ONE TRICHIATIC LASH CORRECTIVE
SURGERY
OPACITIES K OPACITY COVERING
PUPILLARY REGION
30. MANAGEMENT –
PREVENTION
How will you prevent this disease ?
Manage the risk factors
Frequent face wash & hand wash
Prophylactic topical antibiotic therapy -
BLANKET THERAPY:
- In endemic areas
-1% tetracycline e/o 2 times / day –5 days a
month 6 months
31. TREATMENT – ACTIVE
STAGE
TOPICAL:
1% tetracycline / erythromycin
e/o
4 times /day 6 weeks
1% tetracycline e/o bed time6 weeks
34. TREATMENT- “nutshell”
SAFE STRATEGY
S – surgery for trichiasis & entropion
A – antibiotic (erythromycin)
F – face washing
E – environmental hygiene
35. Management in a community
prevalence of
trachoma in
children 1-10 yrs
treatment Eye health
promotion
TF≥20%
TI≥5%
MASS TOPICAL
IF SEVERE- SYSTEMIC
SANITATION, FLIES
CONTROL, PERSONAL
HYGIENE,AB RX
DURING OUTBREAKS
TF 5-20% MASS TOPICAL
IF SEVERE -
SYSTEMIC
AS ABOVE
TF< 5% INDIVIDUAL TOPICAL
RX
CASE FINDING
46. FUNGAL CONJUNCTIVITIS
By aspergillus, candida, nocardia, leptothrix,
sporothrix
Modes of presentation:
Follicular conjunctivitis with lymphadenopathy
Ulcerative / pseudomembranous
Granulomatous actinomycosis,
sporotrichosis, rhinosporidiosis
Rx : topical miconazole or clotrimazole 1%
47. NON SPECIFIC
CONJUNCTIVITIS
Continuation of simple conjunctivitis
Chronic irritation: smoke, dust, heat, alcohol
abuse,etc
Hypersensitivity to allergen
Concretion, trichiasis, blepharitis,
dacryocystitis, chronic rhinitis
Symptoms:
burning & grittiness ^^ in the evening
48. Non specific conjunctivitis
Signs: lower lid congestion
sticky mucous membrane
Rx:
Short course of antibiotics
Eliminate the cause
Lubricants